Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Julian Norman Kenyon"'
Autor:
Shivan Barungi, Macarena Perán, Pablo Hernández-Camarero, Julian Norman Kenyon, Aitor González-Titos, Juan A. Marchal
Publikováno v:
Expert opinion on biological therapy. 21(12)
Introduction: Trypsinogen and chymotrypsinogen have been used clinically in tissue repair due to their ability to resolve inflammatory symptoms. Recently, novel evidence has supported the anti-tumo...
Autor:
Elena López-Ruiz, Macarena Perán, Julian Norman Kenyon, Carlos Chocarro-Wrona, Juan A. Marchal, Carmen Griñán-Lisón, Pablo Hernández-Camarero, María Ángel García
Publikováno v:
Scientific Reports
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Scientific Reports, Vol 9, Iss 1, Pp 1-17 (2019)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Scientific Reports, Vol 9, Iss 1, Pp 1-17 (2019)
Cancer stem cells (CSCs) subpopulation within the tumour is responsible for metastasis and cancer relapse. Here we investigate in vitro and in vivo the effects of a pancreatic (pro)enzyme mixture composed of Chymotrypsinogen and Trypsinogen (PRP) on
Autor:
Julian Norman Kenyon, María Ángel García, Shorena Nadaraia-Hoke, Ralf Brandt, Macarena Perán, Elena López-Ruiz, Juan A. Marchal
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Proteolytic enzymes have shown efficacy in cancer therapy. We present a combination of the two pro-enzymes Trypsinogen and Chymotrypsinogen A with potent in vitro and in vivo anti-tumour efficacy. A synergetic anti-tumour effect for Trypsinogen and C
Publikováno v:
Cellular Oncology. 36:289-301
Background Previous research has suggested a putative utility of pancreatic (pro)enzymes in cancer treatment. The aim of the present study was to investigate the in vitro effects of a mixture of two pancreatic pro-enzymes, i.e., Chymotrypsinogen and
Publikováno v:
Current Drug Therapy. 6:12-16
Sonodynamic Photodynamic Therapy (SPDT) is a novel cancer treatment approach using a photosensitive agent (Sonnelux-1) with reported ultrasound-activated properties. The sensitiser is administered prior to a cycle of light and low-intensity ultrasoun
Publikováno v:
Current Drug Therapy. 4:179-193
Activated Ca ncer Ther apy ( ACT), al so know n a s Sonodyna mic Phot odynamic Ther apy ( SPDT) i s a nove l therapeutic modality that utilises a non-toxic photosensitive agent with reported ultrasound-activated properties. SPDT has previously demons
Autor:
Hamza Butt, Julian Norman Kenyon, Paul S. Noakes, Richard Fuller, Philip C. Calder, Tat Shing Yam
Publikováno v:
Nutrition (Burbank, Los Angeles County, Calif.). 28(6)
Objective Wellmune WGP is a food supplement containing a refined 1,3/1,6 glucopolysaccharide that improves the antimicrobial activity of the innate immune cells by the priming of lectin sites. This study aimed to investigate whether Wellmune decrease